Literature DB >> 9716368

Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.

H H Hansen1, J D Mikkelsen.   

Abstract

Chronic administration of clomipramine or other serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibitors to neonatal rats produces behaviours that resemble a depressive state in the adult animal, and this model is therefore regarded as a putative animal model of depression. Alterations in the activity of the central 5-HT system are important in understanding the pathophysiology of depression, and therefore, we examined whether this model was associated with changes in the expression of 5-HT1A receptor, 5-HT1B receptor, and 5-HT transporter mRNA in the dorsal raphe nucleus and the hippocampus. Wistar rats were injected twice daily with the serotonin reuptake inhibitors clomipramine and 5-chloro-1-[3-(dimethylamino)propyl]-1-(4-fluoro-phenyl)-1,3-dihydroi so-benzofurane, hydrochloride (code Lu 10-134-C) at doses of 15 mg kg(-1) or vehicle i.p. from postnatal day 8 for 14 days. Groups of rats (n = 10) were either killed the day after the last injection or left undisturbed for 69 days before they were killed. The expression of 5-HT transporter, 5-HT1A receptor, and 5-HT1B receptor mRNA was examined in the dorsal raphe nucleus and in the CA1 of the hippocampus by means of quantitative in situ hybridisation histochemistry. Both compounds resulted in an increase in 5-HT transporter mRNA expression (40% more than vehicle) in the dorsal raphe nucleus the day after the last injection (postnatal day 22). A small but significant increase in 5-HT1B receptor mRNA expression in the CA1 was seen after clomipramine, but not after Lu 10-134-C, probably reflecting clomipramine's affinity for both the 5-HT and noradrenaline transporters as well as for a number of monoamine receptor sites. Levels of 5-HT1A receptor mRNA were unchanged. In contrast, 5-HT transporter mRNA expression in the dorsal raphe nucleus was significantly decreased in the adult after neonatal treatment with either of the two drugs compared to vehicle. No changes in 5-HT1A receptor and 5-HT1B receptor mRNA expression were observed in any of the regions examined in these animals. The results show that the persistent depressive behaviour previously shown in this model is also associated with changes in the expression of 5-HT transporter mRNA. This long-term alteration in gene expression may result from disturbances in 5-HT neurotransmission in the brain of the neonatal animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716368     DOI: 10.1016/s0014-2999(98)00349-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.

Authors:  Regina C Casper; Allyson A Gilles; Barry E Fleisher; Joan Baran; Gregory Enns; Laura C Lazzeroni
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

2.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

3.  Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Authors:  V Bhagya; B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2010-11-04       Impact factor: 4.530

4.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming.

Authors:  Kathryn L Ponder; Amy Salisbury; Bethany McGonnigal; Alyse Laliberte; Barry Lester; James F Padbury
Journal:  Dev Psychobiol       Date:  2011-05-05       Impact factor: 3.038

6.  Adverse early life experience and social stress during adulthood interact to increase serotonin transporter mRNA expression.

Authors:  Katherine L Gardner; Matthew W Hale; Stafford L Lightman; Paul M Plotsky; Christopher A Lowry
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

7.  Development × environment interactions control tph2 mRNA expression.

Authors:  J L Lukkes; J M Kopelman; N C Donner; M W Hale; C A Lowry
Journal:  Neuroscience       Date:  2013-02-09       Impact factor: 3.590

Review 8.  Developmental effects of SSRIs: lessons learned from animal studies.

Authors:  Xenia Borue; John Chen; Barry G Condron
Journal:  Int J Dev Neurosci       Date:  2007-07-07       Impact factor: 2.457

9.  Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus.

Authors:  Y Kroeze; D Peeters; F Boulle; J L Pawluski; D L A van den Hove; H van Bokhoven; H Zhou; J R Homberg
Journal:  Transl Psychiatry       Date:  2015-09-22       Impact factor: 6.222

10.  The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.

Authors:  J D A Olivier; H Akerud; H Kaihola; J L Pawluski; A Skalkidou; U Högberg; I Sundström-Poromaa
Journal:  Front Cell Neurosci       Date:  2013-05-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.